MiNK Therapeutics, Inc. (INKT) Ownership

$0.90

north_east
$0.01 (1.68%)
Day's range
$0.86
Day's range
$0.92

MiNK Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VANGUARD GROUP INC 02/11/2025 234,182 $163,225   0.00% 0.59%
LONGBOW FINANCE SA 02/04/2025 166,666 $116,150   0.00% 0.42%
RENAISSANCE TECHNOLOGIES LLC 02/13/2025 101,707 $70,879   -4.67% 0.26%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 96,113 $66,998   -1.91% 0.24%
BLACKROCK FUNDING, INC. /DE 02/07/2025 88,281 $61,523   0.18% 0.22%
HIGHTOWER ADVISORS, LLC 02/07/2025 50,676 $35,316   -2.03% 0.13%
STATE STREET CORP 02/14/2025 25,515 $17,781   0.00% 0.06%
GREENWICH WEALTH MANAGEMENT LLC 02/10/2025 10,805 $8,000   0.00% 0.03%
WELLS FARGO & COMPANY/MN 02/13/2025 10,079 $7,024   -4.31% 0.03%
TOWER RESEARCH CAPITAL LLC (TRC) 02/13/2025 5,401 $3,764   34.12% 0.01%
UBS GROUP AG 02/14/2025 2,847 $1,984   -54.17% 0.01%
ADVISOR GROUP HOLDINGS, INC. 02/07/2025 1,431 $1,008   0.00% 0.00%
COVESTOR LTD 02/13/2025 1,049 $1,000   0.00% 0.00%
JPMORGAN CHASE & CO 02/12/2025 325 $227   151.94% 0.00%
BNP PARIBAS ARBITRAGE, SNC 02/14/2025 247 $172   100.00% 0.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 02/11/2025 190 $132   0.00% 0.00%
GAME PLAN FINANCIAL ADVISORS, LLC 01/30/2025 170 $116   0.00% 0.00%
KEY FINANCIAL INC 01/31/2025 43 $30   0.00% 0.00%
ALLWORTH FINANCIAL LP 01/30/2025 2 $3   0.00% 0.00%
FMR LLC 02/13/2025 1 $1   100.00% 0.00%
CLEARSTEAD ADVISORS, LLC 02/10/2025 0 $0   -100.00% 0.00%
CHILTON CAPITAL MANAGEMENT LLC 02/07/2025 0 $0   -100.00% 0.00%
JAFFETILCHIN INVESTMENT PARTNERS, LLC 02/13/2025 0 $0   -100.00% 0.00%
TWO SIGMA SECURITIES, LLC 02/14/2025 0 $0   -100.00% 0.00%
CAPTRUST FINANCIAL ADVISORS 02/14/2025 0 $0   -100.00% 0.00%

MiNK Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 32 institutional investors and hedge funds held shares of MiNK Therapeutics, Inc.. The most heavily invested institutionals were:

VANGUARD GROUP INC: 234,182

Longbow Finance SA: 166,666

RENAISSANCE TECHNOLOGIES LLC: 101,707

GEODE CAPITAL MANAGEMENT, LLC: 96,113

BlackRock Funding, Inc. /DE: 88,281

HighTower Advisors, LLC: 50,676

2.05% of MiNK Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 898,731 shares in the last 24 months. This purchase volume represents approximately $808,858 in transactions.